Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 252

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 252
---
 to such persons, provided that a copy of any such agreement is provided to the Purchaser not less     
 than five days prior to the Effective Date.                                                                                                                                                                                                            |

| 5.2 | Directors’ Obligations |

Nothing in this Agreement shall prevent the Board of Directors from complying with applicable Securities Laws and applicable Laws including, making any disclosures or taking any actions that may be required under applicable Laws (including the QBCA).

| 5.3 | Covenants of the Company Relating to the Arrangement |

| (a) | Subject to the terms and conditions of this Agreement, the Company shall, and shall cause the Subsidiary to,                                                                                                                                             
 perform all obligations reasonably required to be performed by the Company or the Subsidiary under this Agreement, reasonably cooperate with the Purchaser in connection therewith, and do all such other commercially reasonable acts and things as may 
 be necessary or desirable to consummate and make effective, as soon as reasonably practicable, the transactions contemplated by this Agreement and, without limiting the generality of the foregoing, the Company shall and, where appropriate, shall    
 cause the Subsidiary to:                                                                                                                                                                                                                                 |

| (i) | use commercially reasonable efforts to satisfy all conditions precedent in this Agreement and take all steps                                                                                                       
 set forth in the Interim Order and the Final Order applicable to it and comply promptly with all requirements imposed by Law applicable to it or the Subsidiary with respect to this Agreement or the Arrangement; |

A-32

| (ii) | apply for and use commercially reasonable efforts to provide, obtain and maintain all Regulatory Approvals,                                                                                                                                           
 third party notices or other notices and consents, waivers, permits, exemptions, orders, approvals, agreements, amendments or confirmations that are reasonably required or reasonably requested by the Purchaser in connection with the Arrangement, 
 this Agreement or the other transactions contemplated hereby in each case, on terms that are reasonably satisfactory to the Purchaser, and without paying, and without committing itself or the Purchaser to pay, any consideration or incur any      
 liability or obligation without the prior written consent of the Purchaser and, in doing so, keep the Purchaser reasonably informed as to the status of the proceedings related to obtaining such approvals, including providing the Purchaser with   
 copies of all related applications, notices and notifications, in draft form, in order for the Purchaser to provide its reasonable comments thereon, which shall be given due and reasonable consideration;                                           |

| (iii)